Waters Corporation Interest Expense 2011-2026 | WAT

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Waters Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
14.3 M	19 M	98.9 M	48.8 M	44.9 M	49.1 M	48.7 M	48.6 M	56.8 M	44.9 M	36.2 M	34.2 M	30 M	28.1 M	22 M	13.9 M	11 M	38.5 M	-56.5 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
98.9 M	-56.5 M	33.2 M

Quarterly Interest Expense Waters Corporation

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1	2010-Q3	2010-Q2	2010-Q1	2009-Q3	2009-Q2
48 M	26.6 M	14.4 M	14.3 M	-	21.4 M	23.7 M	25.5 M	-	30.4 M	23.3 M	14.4 M	-	12.4 M	-	11.1 M	10.9 M	11.1 M	12 M	10.9 M	11.1 M	10.9 M	13 M	14.1 M	14.2 M	11.5 M	11.4 M	11.6 M	11.7 M	11.4 M	11.7 M	13.8 M	15.3 M	14.8 M	14.1 M	12.7 M	12.1 M	11.7 M	11 M	10.1 M	9.2 M	9.02 M	9.05 M	8.98 M	9.67 M	9.06 M	7.97 M	7.49 M	7.93 M	7.36 M	7.58 M	7.18 M	7.6 M	7.11 M	6.88 M	6.49 M	6.68 M	6.16 M	5.05 M	4.08 M	3.81 M	3.62 M	-2.61 M	-2.86 M	-2.65 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
48 M	-2.86 M	11.6 M

Interest Expense of other stocks in the Diagnostics research industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Enzo Biochem ENZ	494 K	-	-8.98 %	$ 14.8 K	USA
Centogene N.V. CNTG	8.42 M	-	-6.23 %	$ 30.6 M	Germany
Heska Corporation HSKA	4.19 M	-	-	$ 1.31 B	USA
Fulgent Genetics FLGT	153 K	$ 19.5	7.5 %	$ 600 M	USA
Celcuity CELC	5.33 M	$ 92.47	3.96 %	$ 4.32 B	USA
Akumin AKU	118 M	-	-17.87 %	$ 25.9 M	Canada
Co-Diagnostics CODX	106 K	$ 5.76	11.41 %	$ 7.66 M	USA
Castle Biosciences CSTL	144 K	$ 21.6	5.93 %	$ 626 M	USA
Aspira Women's Health AWH	1.81 M	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	-595 K	-	-61.36 %	$ 2.46 M	USA
Guardant Health GH	-10.5 M	$ 133.06	4.75 %	$ 16.7 B	USA
Biocept BIOC	316 K	-	-13.05 %	$ 7.29 M	USA
ICON Public Limited Company ICLR	337 M	$ 152.8	6.18 %	$ 12 B	Irlanda
CareDx, Inc CDNA	524 K	$ 23.12	3.63 %	$ 1.23 B	USA
Illumina ILMN	340 M	$ 168.06	-1.68 %	$ 26 B	USA
Chembio Diagnostics CEMI	2.94 K	-	0.22 %	$ 16.8 M	USA
Check-Cap Ltd. CHEK	13 K	-	-	$ 9.42 M	Israel
Interpace Biosciences IDXG	-394 K	$ 1.79	2.29 %	$ 7.92 M	USA
HTG Molecular Diagnostics HTGM	857 K	-	-20.0 %	$ 1.06 M	USA
Global Cord Blood Corporation CO	6.27 M	-	-	$ 399 M	China
Genetic Technologies Limited GENE	17.6 K	-	-	$ 7.1 B	Australia
Mettler-Toledo International MTD	68.5 M	-	-	$ 24.3 B	Schweiz
DermTech DMTK	-355 K	-	-11.32 %	$ 2.94 M	USA
Lantheus Holdings LNTH	31.3 M	-	-	$ 6.94 B	USA
NeoGenomics NEO	296 K	$ 11.31	11.54 %	$ 1.45 B	USA
Charles River Laboratories International CRL	-22.6 M	$ 185.79	3.29 %	$ 9.21 B	USA
Natera NTRA	4.07 M	$ 222.1	4.84 %	$ 30.4 B	USA
Medpace Holdings MEDP	-5.34 M	$ 458.69	1.75 %	$ 13.2 B	USA
Exact Sciences Corporation EXAS	18.6 M	-	-	$ 19.8 B	USA
National Research Corporation NRC	-95 K	$ 19.75	3.73 %	$ 442 M	USA
Myriad Genetics MYGN	800 K	$ 4.69	6.59 %	$ 434 M	USA
Personalis PSNL	205 K	$ 12.1	12.24 %	$ 1.08 B	USA
Koninklijke Philips N.V. PHG	288 M	$ 25.99	2.52 %	$ 24.6 B	Niderland
Senseonics Holdings SENS	-23 K	$ 7.01	4.32 %	$ 293 M	USA
QIAGEN N.V. QGEN	-6.65 M	-	-	$ 10.6 B	Niderland
Soleno Therapeutics SLNO	2.58 M	-	-	$ 2.69 B	USA
Biomerica BMRA	367	-	-	$ 4.94 M	USA
Laboratory Corporation of America Holdings LH	224 M	$ 260.97	0.79 %	$ 21.7 B	USA
Twist Bioscience Corporation TWST	-903 K	-	-	$ 4.42 B	USA
Thermo Fisher Scientific TMO	-12 M	$ 482.03	1.7 %	$ 182 B	USA
Trinity Biotech plc TRIB	6.75 M	$ 0.68	-2.4 %	$ 244 M	Irlanda
Motus GI Holdings MOTS	211	-	-34.28 %	$ 263 K	Israel
Neogen Corporation NEOG	38.1 M	$ 9.12	3.52 %	$ 1.98 B	USA
Quest Diagnostics Incorporated DGX	26 M	$ 196.12	1.27 %	$ 21.8 B	USA
Invitae Corporation NVTA	56.7 M	-	-	$ 21.2 M	USA